Harvard Bioscience Inc (HBIO) stock
HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3040% above fair value
$9.00−0.08 (-0.88%)
Close on Nov 18, 2026Market cap $40.97MP/E –Yield –
Harvard Bioscience market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Harvard Bioscience's market cap was $44.07M on Nov 11, 2026, against $33.93M a year earlier. Over the last 5 years it ranged from $15.70M to $287.70M, with a median of $117.31M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $44.07M | +47.8% |
| 2025 | Dec 31, 2025 | $29.81M | -67.6% |
| 2024 | Dec 31, 2024 | $92.03M | -59.7% |
| 2023 | Dec 29, 2023 | $228.38M | +97.9% |
| 2022 | Dec 30, 2022 | $115.39M | -59.9% |
| 2021 | Dec 31, 2021 | $287.70M | +72.1% |
| 2020 | Dec 31, 2020 | $167.20M | +44.0% |
| 2019 | Dec 31, 2019 | $116.10M | -2.1% |
| 2018 | Dec 31, 2018 | $118.57M | +3.0% |
| 2017 | Dec 29, 2017 | $115.11M | +9.8% |
| 2016 | Dec 30, 2016 | $104.84M | -11.0% |
| 2015 | Dec 31, 2015 | $117.79M | -35.8% |
| 2014 | Dec 31, 2014 | $183.58M | +26.9% |
| 2013 | Dec 31, 2013 | $144.69M | +14.7% |
| 2012 | Dec 31, 2012 | $126.11M | +14.5% |
| 2011 | Dec 30, 2011 | $110.19M | -9.8% |
| 2010 | Dec 31, 2010 | $122.18M | – |
See a number that looks wrong?